跳至主要内容
临床试验/CTRI/2024/02/062819
CTRI/2024/02/062819招募中2 期

Add-on effect of Shatavaryadi Basti in comparison with Punarnavadi Basti in the management of chronic kidney disease: A randomized comparative clinical trial

All India Institute of Ayurveda, New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients of both genders having age group 21-65 yrs. with confirmed diagnosis of stage up to G4 as per standard KDIGO-CRITERIA, not having undergone RRT were included.
  • 2. Patients under controlled Diabetes and Hypertension with or without conventional medications.

排除标准

  • 1. Patients suffering from Tuberculosis, Malignancy, Pregnancy and lactation, or any other systemic illness.
  • 2. Uncontrolled diabetes and HTN
  • 3. HIV-associated nephropathy and transplant allograph failure
  • 4. Renal Artery stenosis.
  • 5. Neoplasm of Kidney.
  • 6. History of previous kidney transplant.
  • 7. Patients of Congenital Renal Diseases like Autosomal dominant and Recessive Polycystic Kidney disease, Congenital Nephrotic syndrome, Alports syndrome, Fabrys disease and juvenile Nephronophthisis.
  • 8. Patients with other added complications

研究者

发起方
All India Institute of Ayurveda, New Delhi

相似试验